Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG. (June 2020)
- Record Type:
- Journal Article
- Title:
- Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG. (June 2020)
- Main Title:
- Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG
- Authors:
- Taibi, Abdelkader
Lo Dico, Rea
Kaci, Rachid
Naneix, Anne Laure
Mathonnet, Muriel
Pocard, Marc - Abstract:
- Abstract: Background: This study evaluated the histologic response after preoperative systemic therapy (pST) using the Peritoneal Regression Grading Score (PRGS) and tumor regression grade (TRG) classifications for patients with peritoneal metastases (PM) from colorectal cancer (CRC). Methods: Twenty-three patients were selected from a prospective database of 196 patients who underwent CRS followed by HIPEC for synchronous PM from CRC. In all study patients, biopsies of the PM obtained before pST (during the first laparoscopy) and after pST (during cytoreductive surgery) were compared. Results: Complete (PRGS 1), Major (PRGS 2), Minor (PRGS 3) and no histological responses (PRGS 4) were obtained in 17, 5%, 52% and 13% and 17, 5% of patients, respectively. Major (TRG 1–2), partial (TRG3), and no (TRG4-5) histological tumor regression were observed in 61%, 9% and 30% of patients, respectively. Regardless of the classification applied, median OS was significantly higher in patients with a "complete or major" response than in those with a "minor/partial or no" response (54 vs. 26 months, p < 0.05). Conclusions: The PRGS and TRG can be used in clinical practice to evaluate the histological response after pST. This study demonstrated that a complete histologic response of PM from CRC can be obtained after pST. Highlights: Pathologic assessment plays a central role in patient management. Complete histological response has been associated with a favourable clinical outcome. The PRGSAbstract: Background: This study evaluated the histologic response after preoperative systemic therapy (pST) using the Peritoneal Regression Grading Score (PRGS) and tumor regression grade (TRG) classifications for patients with peritoneal metastases (PM) from colorectal cancer (CRC). Methods: Twenty-three patients were selected from a prospective database of 196 patients who underwent CRS followed by HIPEC for synchronous PM from CRC. In all study patients, biopsies of the PM obtained before pST (during the first laparoscopy) and after pST (during cytoreductive surgery) were compared. Results: Complete (PRGS 1), Major (PRGS 2), Minor (PRGS 3) and no histological responses (PRGS 4) were obtained in 17, 5%, 52% and 13% and 17, 5% of patients, respectively. Major (TRG 1–2), partial (TRG3), and no (TRG4-5) histological tumor regression were observed in 61%, 9% and 30% of patients, respectively. Regardless of the classification applied, median OS was significantly higher in patients with a "complete or major" response than in those with a "minor/partial or no" response (54 vs. 26 months, p < 0.05). Conclusions: The PRGS and TRG can be used in clinical practice to evaluate the histological response after pST. This study demonstrated that a complete histologic response of PM from CRC can be obtained after pST. Highlights: Pathologic assessment plays a central role in patient management. Complete histological response has been associated with a favourable clinical outcome. The PRGS and TRG can be used in clinical practice after pST. Abstract : This study evaluated the histological response of peritoneal metastases from colorectal cancer after preoperative systemic therapy. The results demonstrated that complete histological tumour regression can be obtained with preoperative systemic chemotherapy and is a prognostic factor. … (more)
- Is Part Of:
- Surgical oncology. Volume 33(2020)
- Journal:
- Surgical oncology
- Issue:
- Volume 33(2020)
- Issue Display:
- Volume 33, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 33
- Issue:
- 2020
- Issue Sort Value:
- 2020-0033-2020-0000
- Page Start:
- 158
- Page End:
- 163
- Publication Date:
- 2020-06
- Subjects:
- Histological response -- Systemic chemotherapy -- Peritoneal metastases -- Colorectal -- PRGS -- TRG
Cancer -- Surgery -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Electronic journals
616.994059 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09607404 ↗
http://www.so-online.net/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09607404 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09607404 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.suronc.2020.02.014 ↗
- Languages:
- English
- ISSNs:
- 0960-7404
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8548.242000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13398.xml